Chase Coleman - Tiger Global Management
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.26 | SEC | ||
| 2025 Q2 | 1,269,000 | 0.26 | $69.02 | $87,586,380 | SEC | ||
| 2025 Q1 | 1,269,000 | 0.33 | $69.44 | $88,119,360 | SEC | ||
| 2024 Q4 | 1,269,000 | 0.41 | $86.02 | $109,159,380 | SEC | ||
| 2024 Q3 | 1,269,000 | 0.64 | $119.07 | $151,099,830 | SEC | ||
| 2024 Q2 | 1,269,000 | 0.84 | $142.74 | $181,137,060 | SEC | ||
| 2024 Q1 | 1,269,000 | 0.89 | $128.40 | $162,939,600 | SEC | ||
| 2023 Q4 | 1,269,000 | 0.93 | $103.45 | $131,278,050 | SEC | ||
| 2023 Q3 | 1,269,000 | 0.85 | Add 100.00% | 0.43 | $90.94 | $115,402,860 | SEC |
| 2023 Q2 | 634,500 | 0.86 | Buy | 0.86 | $161.83 | $102,681,135 | SEC |